SciVision Biotech Inc Sustainability Reports

SciVision Biotech Inc. develops, manufactures, and distributes medical-grade hyaluronic acid products. Its offerings include synovial fluid supplements, facial dermal implants, and absorbable adhesion barriers.

Sector: Manufacturing

Country: Taiwan

Exchange: Taiwan Stock Exchange

FIGI: BBG001TWPZW5

4 reports from 2021 to 2024

• SciVision Biotech Inc 2024 Parent Company Only Financial Report and Independent Auditor's Report
• SciVision Biotech Inc 2024 Annual Report
• SciVision Biotech Inc 2023 Annual Report
• SciVision Biotech Inc 2021 Annual Report